Cardiff Oncology, Inc. (CRDF)
1.91
+0.21
(+12.35%)
USD |
NASDAQ |
Feb 25, 16:00
1.93
+0.02
(+1.05%)
After-Hours: 20:00
Cardiff Oncology Research and Development Expense (Quarterly) : 8.197M for Sept. 30, 2025
Research and Development Expense (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
R&D Expense Definition
R&D expense is a line item from many companies' income statements.
Research and Development Expense (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Research and Development Expense (Quarterly) Benchmarks
| Agenus, Inc. | 23.60M |
| Inspire Medical Systems, Inc. | 24.94M |
| Outset Medical, Inc. | 5.054M |
| Curis, Inc. | 6.432M |
| LadRx Corp. | 0.0288M |